Moreover, the patient group with high CMKLR1 and RARRES2 expression showed a significantly higher frequency of mesenchymal GBM (Supplementary Table S6), suggesting a tight correlation between the expression of the chemerin/CMKLR1 axis and the mesenchymal phenotype in GBM. Here, RARRES2 is linked to glioblastoma.